Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled Phase 2 study of clenbuterol in spinal and bulbar muscular atrophy
2017-005103-27Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clenbuterol in spinal and bulbar muscular atrophy (SBMA), sponsored by Azienda Ospedaliero-Universitaria di Padova. Started Oct 2020; status: active.
02
Drugs
clenbuterol
03
Conditions
spinal and bulbar muscular atrophy (SBMA)
Beyond the preview
Go deeper on 2017-005103-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005103-27.